[1]
rao, N., Jauhari, R., Godiyal, P., Sati, V. and Babbar, A. 2022. ROPINIROLE VERSUS LEVODOPA: BETTER CLINICAL BENEFITS IN PARKINSON’S DISEASE. Journal of Applied Pharmaceutical Sciences and Research. 5, 3 (Dec. 2022), 17-27. DOI:https://doi.org/10.31069/japsr.v5i3.02.